Commvault Systems Inc vs Medtronic PLC — how do they compare? Commvault Systems Inc trades at $139.62 (market cap $5.78B), while Medtronic PLC trades at $90.5 (market cap $114.45B). The key difference: Medtronic PLC is far larger — about 19.8× Commvault Systems Inc's market cap, and Medtronic PLC pays a 3.22% dividend while Commvault Systems Inc pays none. Which is the better fit depends on your goals.
| CVLT | MDT | |
|---|---|---|
Market Cap | $5.78B | $114.45B |
Sector | Technology | Health |
52-Week High | $195.41 | $105.35 |
52-Week Low | $75.18 | $73.75 |
Enterprise Value | $5.77B | $133.19B |
Dividend Yield | — | 3.22% |
Signals from Pluang's Aura AI — not financial advice
Commvault Systems (CVLT) trades at $135.27, up 1.43% today, with a bullish technical signal and strong earnings beats in recent quarters. The stock shows robust profitability with an 81.09% gross margin and 32.77% ROE, though valuation multiples like a P/E of 89.38 are elevated. Recent news highlights growth in SaaS revenue and new security integrations, such as the Threat Scan partnership with Google, driving positive analyst sentiment.
The outlook remains positive with a consensus price target of $172.40, implying 27% upside, supported by subscription growth and cash flow improvements. Risks include high valuation sensitivity, competitive pressures in data security, and fiduciary duty investigations noted in recent legal alerts, which could impact investor confidence near-term.
No Aura AI signal available yet.
Trailing returns across standard periods
Latest headlines on both assets
Commvault provides enterprise-grade data protection and information management software. Its platform helps businesses manage, back up, and recover data across on-premises, cloud, and hybrid environments.
Read more on CVLT →One of the largest medical device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. The company markets its products to healthcare institutions and physicians in the United States and overseas. Foreign sales account for almost 50% of the company's total sales.
Read more on MDT →